Gilead Sciences Inc (GILD)
64.92
-0.54
(-0.82%)
USD |
NASDAQ |
May 08, 16:00
65.30
+0.38
(+0.59%)
After-Hours: 20:00
Gilead Sciences Total Return Price: 64.92 for May 8, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 08, 2024 | 64.92 |
| May 07, 2024 | 65.46 |
| May 06, 2024 | 65.54 |
| May 03, 2024 | 64.78 |
| May 02, 2024 | 65.33 |
| May 01, 2024 | 65.51 |
| April 30, 2024 | 65.20 |
| April 29, 2024 | 65.94 |
| April 26, 2024 | 65.42 |
| April 25, 2024 | 65.27 |
| April 24, 2024 | 67.08 |
| April 23, 2024 | 67.03 |
| April 22, 2024 | 66.95 |
| April 19, 2024 | 66.76 |
| April 18, 2024 | 66.16 |
| April 17, 2024 | 66.93 |
| April 16, 2024 | 67.31 |
| April 15, 2024 | 67.75 |
| April 12, 2024 | 68.07 |
| April 11, 2024 | 68.65 |
| April 10, 2024 | 68.12 |
| April 09, 2024 | 69.94 |
| April 08, 2024 | 69.42 |
| April 05, 2024 | 69.58 |
| April 04, 2024 | 69.55 |
| Date | Value |
|---|---|
| April 03, 2024 | 70.89 |
| April 02, 2024 | 72.09 |
| April 01, 2024 | 72.88 |
| March 28, 2024 | 73.25 |
| March 27, 2024 | 73.01 |
| March 26, 2024 | 72.41 |
| March 25, 2024 | 72.58 |
| March 22, 2024 | 72.61 |
| March 21, 2024 | 73.09 |
| March 20, 2024 | 73.98 |
| March 19, 2024 | 73.41 |
| March 18, 2024 | 73.26 |
| March 15, 2024 | 73.69 |
| March 14, 2024 | 74.21 |
| March 13, 2024 | 75.17 |
| March 12, 2024 | 74.32 |
| March 11, 2024 | 74.56 |
| March 08, 2024 | 74.36 |
| March 07, 2024 | 72.91 |
| March 06, 2024 | 71.89 |
| March 05, 2024 | 72.25 |
| March 04, 2024 | 71.52 |
| March 01, 2024 | 71.58 |
| February 29, 2024 | 71.37 |
| February 28, 2024 | 71.96 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
49.52
Minimum
Dec 30 2020
86.40
Maximum
Jan 19 2024
63.81
Average
61.06
Median
Aug 02 2021
Total Return Price Benchmarks
| Amgen Inc | 307.31 |
| CymaBay Therapeutics Inc (DELISTED) | -- |
| Bristol-Myers Squibb Co | 43.67 |
| Eli Lilly and Co | 775.00 |
| Xilio Therapeutics Inc | 1.21 |